- Who We Are
Pharma Marketing Agency. Medical Communications. One Partner.
The pharmaceutical companies that lead their therapy areas do not leave commercial success to chance. They choose a partner who understands both the science behind the molecule and the market reality it has to navigate.
OneAlphaMed is that partner – India’s pharma marketing agency and medical communications company built exclusively for the pharmaceutical and life sciences sector. We deliver pharma brand strategy and product launch, medical affairs and scientific communications, digital innovation and pharma AI solutions, and patient advocacy and support from one integrated team, in 35+ countries. One brief. One scientific narrative. One commercial outcome.
Global Experts
0
+
Countries
0
+
HCP Touch Points
1
M+
PG Students Reached
0
K+
- What We Do
Four Integrated Service Pillars. One Pharma Growth Partner.
From pharmaceutical marketing strategy and pharma brand management to medical affairs, pharma AI, and patient advocacy - OneAlphaMed delivers the full commercial and scientific capability stack that regional and global pharmaceutical companies need under one roof.
Brand Strategy & Market Launch
Pharma brand strategy that earns prescribers and wins payers.
Services:
- Product Launch Strategy
- Omnichannel Marketing Plans
- Scientific Messaging
- Market Access & HEOR
Medical Affairs & Evidence
Medical communications services grounded in evidence, not just narrative.
Services:
- Real-World Evidence (RWE)
- Strategic Publication Planning
- KOL Advisory Boards
- Regulatory Compliance
Digital Innovation & Pharma AI
Pharma AI solutions and pharma digital marketing strategy built for compliance - not adapted from other industries.
Services:
- HCP AI Chatbots (MERLIN)
- Pharma LMS
- KOL Portals
- Clinical Data OCR
Patient Advocacy & Support
Patient support programs that sustain adherence through the full therapy journey.
Services:
- Therapy Onboarding Hubs
- Connected Adherence & AI
- Patient Access Programs
- Gamified Patient Education
India's Pharma Marketing Agency. Global Life Sciences Reach.
OneAlphaMed was founded to close the gap that most pharmaceutical companies experience between clinical innovation and commercial success – where strong science and weak commercial execution produce launches that underperform their clinical promise.
We are a healthcare marketing agency, medical communications agency, and pharmaceutical consulting services partner operating exclusively in the pharmaceutical and life sciences sector. Our model integrates brand strategy, scientific communications, AI-powered digital innovation, and patient advocacy into one coordinated commercial capability – across Brand Strategy & Launch, Medical Affairs & Evidence Generation, Digital Innovation & Pharma AI, and Patient Advocacy & Support.
With 500+ global experts spanning 35+ countries, we deliver the pharma communications and life sciences marketing standards that Sun Pharma, JB Chemicals, Bayer, Hetero, Novo Nordisk, Mankind, ERIS, Lupin, Pfizer, MAX Healthcare, Aurobindo, Anthem Biosciences, Olympus, ResMed, Wockhardt, P&G Health, Meril, Metropolis, GSK, Abbott, Zydus, Medtronic, Cipla, and Dr. Reddy’s rely on across India and global markets.
- The OAM Difference
The OneAlphaMed Difference
India has pharma marketing agencies. It has medical communications companies. Very few combine both disciplines and none combine them with proprietary AI and a 5,000+ KOL network – in a single pharma-dedicated team.
Evidence-Based Prescribing Impact
Every pharmaceutical marketing strategy and healthcare brand strategy we build is grounded in clinical evidence. HCP engagement journeys are sequenced around what prescribers actually respond to, tracked through closed-loop CRM analytics, and continuously optimised toward measurable prescribing behaviour change.
Integrated Omnichannel HCP Journeys
Pharma communications that exist in silos – field force separate from digital, congress separate from CRM produce inconsistent brand experiences and wasted spend. We connect every touchpoint into one coherent HCP engagement journey, personalised by prescriber segment and stage.
Unified Therapy Area Narratives
Brand strategy, medical affairs, and scientific communications that tell three different stories to the same prescriber are a credibility gap waiting to be exploited by a competitor. Our Unified Therapy Area Storytelling model gives medical affairs, commercial, and market access one defensible scientific narrative across every channel.
Compliance-First Digital Innovation
MERLIN AI: our proprietary RAG-based pharma language model – answers HCP medical queries from verified scientific sources only, with air-gapped security and mandatory audit trails. The Innomed Portal manages 5,000+ KOL and DOL relationships at scale. These are not generic AI tools adapted for pharma. They were built for it.
Pan-India Execution, Global Expertise
We understand the Indian pharmaceutical market – DCGI timelines, UCPMP compliance, Tier-2 and Tier-3 city HCP engagement – better than any global network agency. And with active programmes across Southeast Asia and international markets, we bring that depth to global pharma launches too.
- Common Questions
Frequently Asked Questions
OneAlphaMed is India's pharma marketing agency and medical communications agency - built exclusively for pharmaceutical and life sciences companies. We work across Brand Strategy & Product Launch, Medical Affairs & Evidence-Based Solutions, Digital Innovation & Pharma AI, and Patient Advocacy & Support Services. But the part that matters most is not the list of services. It is that all four come from one team, on one brief. Brand strategy and scientific credibility stop being two separate conversations because they were never separated to begin with.
Yes. OneAlphaMed operates across India, Southeast Asia, and global markets through a network of 500+ experts spanning 35+ countries. We deliver pharma brand strategy, pharmaceutical marketing strategy, medical affairs programmes, and life sciences marketing to the standards that regional and global pharmaceutical companies expect - with deep India-first expertise that global network agencies cannot replicate.
OneAlphaMed builds and deploys pharma-specific AI tools engineered for the regulatory environment of the pharmaceutical industry - not generic tools adapted from other sectors. MERLIN AI is our proprietary Retrieval-Augmented Generation (RAG) medical information engine, trained exclusively on verified sources including PubMed and peer-reviewed clinical journals, with air-gapped security and mandatory audit trails. The Innomed Portal is our proprietary platform for managing KOL and Digital Opinion Leader relationships at scale. We also build AI chatbots for HCPs, intelligent document processing systems for clinical data, and adaptive learning management systems for medical education - all HIPAA-compliant and designed to pass MLR review without manual rewriting.
A pharma digital marketing strategy is the framework that determines how digital touchpoints connect to field force activity, congress presence, and medical education into one coherent HCP experience. It involves HCP segmentation, Next Best Action frameworks, closed-loop CRM analytics, content sequencing by prescriber journey stage, and compliance architecture that keeps every digital interaction inside regulatory bounds. Done well, it makes every rupee of digital spend work harder because it is not running in parallel with the rest of the brand - it is running as part of it.
- Let's Talk
Connect with a Strategic Advisor
Reach out for appointments, strategic discussions, or partnership enquiries.
We get back quickly and point you to exactly the right solution.
Our Partners
